Akumin Inc. Announces Fiscal 2017 Financial Results

TORONTO, April 2, 2018 /CNW/ - Akumin Inc. (TSX:AKU.U) ("Akumin" or the "Corporation") announced today its financial results for the quarter ended December 31, 2017 ("December 2017 Quarter") and the fifteen-month period ended December 31, 2017 ("Fiscal 2017"). Note that, in Fiscal 2017, the Corporation changed its year-end from September 30 to December 31. As a result, the Corporation is reporting a one-time, fifteen-month transition year, covering the period from October 1, 2016 to December 31, 2017. To facilitate period-to-period comparisons, the comparative period for December 2017 Quarter is the three-months ended December 31, 2016 and the comparative period for Fiscal 2017 is the twelve-months ended September 30, 2016 ("Fiscal 2016").

Summary Consolidated Financial Results (in thousands, except for per share amounts)
	15-months ended Dec. 31, 2017	12-months ended Sep. 30, 2016	3-months ended Dec. 31, 2017	3-months ended Dec. 31, 2016
Revenue	110,746	46,401	37,585	15,227
EBITDA ^(1)	3,476	4,381	6,142	1,397
Adjusted EBITDA ^(1)	16,572	6,021	8,272	1,697
Net Income (loss) attributable to common shareholders	(8,504)	(1,986)	2,579	(342)
Basic earnings (loss) per share	(0.27)	(0.09)	0.06	(0.01)
Diluted earnings (loss) per share	(0.27)	(0.09)	0.06	(0.01)

⁽¹⁾ See "Non-Financial Measures" below.

Please note that the Corporation's consolidated financial statements for Fiscal 2017, related management's discussion and analysis, annual information form, and management information circular are available under Akumin's profile on SEDAR (www.sedar.com).

Commenting on the Fiscal 2017 financial results, Riadh Zine, President and Chief Executive Officer of the Corporation, said, "Fiscal 2017 was a seminal year for Akumin. We continued our investment in our operating infrastructure and our people, and we executed on our go public strategy. Our strong December 2017 Quarter and Fiscal 2017 performance demonstrates our ability to drive consistent profitable growth. Looking ahead, we remain focused on increasing our revenues organically and through acquisitions that fit our strategic criteria, and on reducing our expenses with continued implementation of operating efficiencies. Above all, we believe our commitment to provide customized care, convenience and consistency, all at competitive rates for our customers, has enabled us to deliver good results and will continue to distinguish us going forward."

At the end of Fiscal 2017, the Corporation had a total of 74 medical diagnostic imaging facilities throughout the United States, as compared to 39 facilities which existed at the end of Fiscal 2016.

Unless otherwise indicated, all amounts are expressed in U.S. dollars. Certain metrics, including those expressed on an adjusted or comparable basis, are non-IFRS measures. See "Non-IFRS Measures" and "Selected Consolidated Financial Information" of this press release for further details.

About Akumin

Akumin is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States with a network of 74 owned and/or operated imaging centers located in Florida, Pennsylvania, Delaware, Texas, Illinois and Kansas. By combining our clinical expertise with the latest advances in technology and information systems, our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. Our imaging procedures include MRI, CT, positron emission tomography (PET), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures.

Non-IFRS Measures

This press release makes reference to certain non-IFRS measures. These non-IFRS measures are not recognized measures under the International Financial Reporting Standards ("IFRS") and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-IFRS measures are provided as additional information to complement those IFRS measures by providing further understanding of our results of operations from management's perspective. Accordingly, these non-IFRS measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. We use non-IFRS financial measures, including "EBITDA", "Adjusted EBITDA" and "Adjusted EBITDA Margin". These non-IFRS measures are used to provide investors with supplemental measures of our operating performance and thus highlight trends in our core business that may not otherwise be apparent when relying solely on IFRS measures. We also believe that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Our management uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts, and to determine components of management compensation. Definitions and reconciliations of non-IFRS measures to the relevant reported measures can be found in our Management's Discussion and Analysis dated March 29, 2018 available at www.sedar.com.

We define such non-IFRS measures as follows:

"EBITDA" means net income (loss) attributable to shareholders of the Corporation before interest expense (net), income tax expense (recovery) and depreciation and amortization.

"Adjusted EBITDA" means EBITDA as further adjusted for stock-based compensation, impairment of property and equipment, provisions for certain bad debts, gains (losses) in the period, settlement costs, provisions and public offering and acquisition-related costs.

"Adjusted EBITDA Margin" means Adjusted EBITDA divided by the total revenue in the period.

Forward-Looking Information

Certain information in this press release constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.

Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the "Risk Factors" section of our Annual Information Form and Management's Discussion and Analysis, each dated March 29, 2018 available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Selected Consolidated Financial Information

	3-months ended	3-months ended	15-months ended	12-months ended
(in thousands)	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Sep 30, 2016
Service fees – net of contractual allowances and discounts	36,679	14,319	107,490	45,126
Other Revenue	906	908	3,256	1,275
Total revenue	37,585	15,227	110,746	46,401
Provision for bad debts	2,347	573	5,273	1,821
Employee compensation	11,354	5,674	38,468	15,721
Reading fees	4,598	2,240	15,582	7,216
Rent and utilities	3,261	2,037	12,987	5,328
Third party services and professional fees	2,798	1,464	8,832	5,623
Administrative	2,156	677	5,776	2,149
Medical supplies and other expenses	1,199	864	5,101	2,522
Depreciation and amortization	2,063	853	6,480	3,213
Stock-based compensation	570	231	3,242	714
Interest expense	1,398	876	5,376	3,152
Provision for other bad debts related to transition services agreement	-	-	-	313
Impairment of property and equipment	341	130	601	354
Settlement costs (recoveries)	(221)	-	(192)	134
Provisions	-	25	725	1,652
Acquisition-related costs	714	-	4,256	125
Public offering costs	1,021	-	1,520	-
Financial instruments revaluation, foreign exchange (gain) loss, and other (gains) losses	(295)	(85)	2,944	(1,651)
Income (loss) before income taxes	4,281	(332)	(6,225)	(1,985)
Income tax provision	102	10	124	1
Non-controlling interests	1,600	-	2,155	-
Net income (loss) and comprehensive income (loss) for period attributable to shareholders of Akumin	2,579	(342)	(8,504)	(1,986)
Adjusted EBITDA	3-months ended	3-months ended	15-months ended	12-months ended
(in thousands)	Dec 31, 2017	Dec 31, 2016	Dec 31, 2017	Sep 30, 2016
Service fees – net of contractual allowances and discounts	36,679	14,319	107,490	45,126
Other Revenue	906	908	3,256	1,275
Total revenue	37,585	15,227	110,746	46,401
Provision for bad debts	2,347	573	5,273	1,821
Employee compensation	11,354	5,674	38,468	15,721
Reading fees	4,598	2,240	15,582	7,216
Rent and utilities	3,261	2,037	12,987	5,328
Third party services and professional fees	2,798	1,464	8,832	5,623
Administrative	2,156	677	5,776	2,149
Medical supplies and other expenses	1,199	864	5,101	2,522
Sub-total	27,713	13,529	92,019	40,380
Non-controlling interests	1,600	-	2,155	-
Adjusted EBITDA	8,272	1,697	16,572	6,021

SOURCE Akumin Inc.

Riadh Zine, President and Chief Executive Officer, 416-613-1391